WIPO Seminar On TK, Genetic Resources: Variations In Public Domain, Disclosure 09/04/2015 by Catherine Saez, Intellectual Property Watch 1 Comment The concept of public domain was born out of the intellectual property system, according to some. However, what constitutes the public domain depends on national interpretations. A recent seminar organised by the World Intellectual Property Organization was an occasion for speakers from diverse horizons to present their experience in the context of traditional knowledge and genetic resources. The relevance of a disclosure requirement in patent application to prevent wrongful patents was also discussed. [Note: Article 2 of 2]
WIPO Seminar Displays National Efforts To Protect TK, Folklore 08/04/2015 by Catherine Saez, Intellectual Property Watch 4 Comments A recent seminar convened by the World Intellectual Property Organization shed light on national and regional legislations protecting traditional knowledge, folklore and genetic resources, and provided examples of misappropriation. WIPO has a committee dealing with these issues but disagreement among members on its work programme prevented the organisation from organising any meeting of the committee so far this year. [Note: Article 1 of 2]
Interrelations Between Plant Treaty, UPOV, WIPO, Farmers’ Rights – Do They Equate? 02/04/2015 by Catherine Saez, Intellectual Property Watch 6 Comments Farmers’ rights are enshrined in the international plant treaty. However, their implementation is an ongoing issue, which the plant treaty is seeking to address by looking at the interrelation that might exist with other international instruments. Separately, civil society is asserting that the World Intellectual Property Organization favours the International Union for the Protection of New Varieties of Plants (UPOV) in its technical assistance. But the WIPO Director General countered that this is decidedly not the case.
WHO Issues Guideline For Manufacturers Of Generic Hepatitis C Medicine 02/04/2015 by Catherine Saez, Intellectual Property Watch 3 Comments The World Health Organization has issued a guidance document on the design of bioequivalence studies for a leading hepatitis C medicine. Generic drug companies seeking prequalification by the WHO need to demonstrate that their generic version is equivalent to the originator drug.
EPO Backs Patents On Conventional Plants: Broccoli, Tomato Cases Decided 01/04/2015 by Catherine Saez, Intellectual Property Watch 12 Comments The highest court of the European Patent Office has declared that plants or seeds obtained through conventional breeding methods are patentable.
Supplier of Essential Medicines Supports TRIPS Waiver For Least-Developed Countries 30/03/2015 by Catherine Saez, Intellectual Property Watch 5 Comments The IDA Foundation, a worldwide supplier of essential medicines to low-and medium income countries, has backed the request by least-developed countries to extend a waiver that allows them to forfeit the obligations to protect intellectual property on pharmaceutical products. UNITAID, the UN-related drug purchasing mechanism, also issued a statement in support of the extension. The request is expected to be discussed at the World Trade Organization in June.
Busy Year At WTO: 20th Anniversary, Doha Round, Dispute Settlement Overload 26/03/2015 by Catherine Saez, Intellectual Property Watch 1 Comment This year is an auspicious moment for the World Trade Organization and the multilateral trading system, WTO Director General Roberto Azevêdo told journalists today. In particular, he said, the WTO, after a hiatus last year, is implementing the results of the 2013 Bali agreement on trade facilitation and finalising work on the work programme to conclude the Doha Round of trade liberalisation negotiations.
Indian Draft Pesticides Bill Contains TRIPS-Plus Data Exclusivity, Indian Pharma Says 26/03/2015 by Catherine Saez, Intellectual Property Watch 3 Comments India is considering legislation on pesticides containing data exclusivity provisions that would raise the level of intellectual property protection above the minimum required by international trade agreements and could act as a precursor for pharmaceutical products in the country, a leading Indian industry representative warned this week. India is sensitive to restrictions on the use of marketing data of patented pharmaceuticals as it is seen as the world leader in generic medicines, which use such data.
Patent On Conventional Plant Dismissed For Lack Of Novelty, Firm Says 24/03/2015 by Intellectual Property Watch Leave a Comment The District Court of The Hague (Netherlands) ruled last week that a patent for red radish plants is invalid in the Netherlands for lack of novelty but did not rule on the fact that the particular plant was bred using essential biological processes. The case, between two Dutch companies, related to red radish sprouts on which one company held a patent.
Open Source Model In Computers Should Be Applied To Genomic Data, Paper Says 22/03/2015 by Intellectual Property Watch Leave a Comment Genomic data should be made publicly available for the promotion of science as a global public good, a new paper argues. Two researchers suggest that a model inspired by the open-source computer software movement should be developed for plant breeding, animal breeding, and biomedicine.